BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23165914)

  • 21. Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor.
    Jaime-Pérez JC; Pinzón-Uresti MA; Jiménez-Castillo RA; Colunga-Pedraza JE; González-Llano Ó; Gómez-Almaguer D
    Hematology; 2018 Jan; 23(1):1-9. PubMed ID: 28580844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: results of the Cooprall-97 study.
    Domenech C; Mercier M; Plouvier E; Puraveau M; Bordigoni P; Michel G; Benoit Y; Leverger G; Baruchel A; Bertrand Y
    Eur J Cancer; 2008 Nov; 44(16):2461-9. PubMed ID: 18804997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis of relapsed or primary refractory childhood lymphoblastic lymphoma in Japan.
    Mitsui T; Mori T; Fujita N; Inada H; Horibe K; Tsurusawa M;
    Pediatr Blood Cancer; 2009 May; 52(5):591-5. PubMed ID: 19156862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
    Schroeder H; Garwicz S; Kristinsson J; Siimes MA; Wesenberg F; Gustafsson G
    Med Pediatr Oncol; 1995 Nov; 25(5):372-8. PubMed ID: 7674994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999.
    Tsuchida M; Ohara A; Manabe A; Kumagai M; Shimada H; Kikuchi A; Mori T; Saito M; Akiyama M; Fukushima T; Koike K; Shiobara M; Ogawa C; Kanazawa T; Noguchi Y; Oota S; Okimoto Y; Yabe H; Kajiwara M; Tomizawa D; Ko K; Sugita K; Kaneko T; Maeda M; Inukai T; Goto H; Takahashi H; Isoyama K; Hayashi Y; Hosoya R; Hanada R;
    Leukemia; 2010 Feb; 24(2):383-96. PubMed ID: 20033052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of central nervous system involvement at diagnosis of childhood T-cell acute lymphoblastic leukemia.
    Jaing TH; Yang CP; Hung IJ; Tsay PK; Tseng CK; Chen SH
    Pediatr Blood Cancer; 2005 Aug; 45(2):135-8. PubMed ID: 15704218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome.
    Meyr F; Escherich G; Mann G; Klingebiel T; Kulozik A; Rossig C; Schrappe M; Henze G; von Stackelberg A; Hitzler J
    Br J Haematol; 2013 Jul; 162(1):98-106. PubMed ID: 23594030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
    J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J; Filippa DA; Qin J; Wollner N
    Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies of children with acute lymphoblastic leukemia (ALL) who relapsed. Relationship of site of relapse, time and prognosis].
    Shimizu H; Sasaki K; Takaue Y; Ota S; Fzjimoto T
    Rinsho Ketsueki; 1989 Jul; 30(7):999-1004. PubMed ID: 2810802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia.
    Specchia G; Pastore D; Carluccio P; Liso A; Mestice A; Rizzi R; Ciuffreda L; Pietrantuono G; Liso V
    Ann Hematol; 2005 Nov; 84(12):792-5. PubMed ID: 16047203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.
    Gorman MF; Ji L; Ko RH; Barnette P; Bostrom B; Hutchinson R; Raetz E; Seibel NL; Twist CJ; Eckroth E; Sposto R; Gaynon PS; Loh ML
    Pediatr Blood Cancer; 2010 Sep; 55(3):421-9. PubMed ID: 20658611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.
    Paganin M; Zecca M; Fabbri G; Polato K; Biondi A; Rizzari C; Locatelli F; Basso G
    Leukemia; 2008 Dec; 22(12):2193-200. PubMed ID: 18754029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pattern of relapsed disease in childhood all: experience from a single tertiary care center in North India.
    Kulkarni KP; Marwaha RK; Trehan A; Bansal D
    Pediatr Hematol Oncol; 2009 Sep; 26(6):398-406. PubMed ID: 19657989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical features and prognostic analysis of testicular relapse in pediatric acute lymphoblastic leukemia].
    Wang N; Gao YY; Qi BQ; Ruan M; Lyu H; Zhang XY; Zhang RR; Liu TF; Chen YM; Zou Y; Guo Y; Yang WY; Zhang L; Zhu XF; Chen XJ
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):262-267. PubMed ID: 38378289
    [No Abstract]   [Full Text] [Related]  

  • 38. Testicular relapse in childhood acute lymphoblastic leukemia: the challenges and lessons.
    Kulkarni KP; Marwaha RK; Trehan A; Bansal D
    Indian J Cancer; 2010; 47(2):134-8. PubMed ID: 20448374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.
    Malempati S; Gaynon PS; Sather H; La MK; Stork LC;
    J Clin Oncol; 2007 Dec; 25(36):5800-7. PubMed ID: 18089878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second neoplasms after acute lymphoblastic leukemia in childhood.
    Neglia JP; Meadows AT; Robison LL; Kim TH; Newton WA; Ruymann FB; Sather HN; Hammond GD
    N Engl J Med; 1991 Nov; 325(19):1330-6. PubMed ID: 1922234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.